Incidence and causes of overdiagnosis of myasthenia gravis

Nirmal Andrapalliyal1, Benjamin Claytor1, Yuebing Li1

  • 1Department of Neurology, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Muscle & Nerve
|December 19, 2022
PubMed
Abstract

Insights

Overdiagnosis of myasthenia gravis (MG) is common, with 14.5% of patients misdiagnosed. Factors include atypical symptoms and misleading tests, especially in seronegative cases. Accurate diagnosis requires careful evaluation.

Area of Science:

  • Neurology
  • Clinical Diagnostics

Background:

  • Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
  • Accurate diagnosis is crucial for effective treatment and patient outcomes.
  • Overdiagnosis of MG can lead to inappropriate management and delayed diagnosis of correct conditions.

Purpose of the Study:

  • To investigate the frequency of myasthenia gravis overdiagnosis.
  • To identify factors contributing to the misdiagnosis of MG.

Main Methods:

  • Retrospective analysis of 531 patients referred for a second opinion on their MG diagnosis.
  • Review of clinical presentation, serological tests (acetylcholine receptor antibodies, striational antibodies), and electrodiagnostic studies (repetitive nerve stimulation, single-fiber electromyography).

Main Results:

  • 77 out of 531 patients (14.5%) with a suspected or confirmed MG diagnosis were found to have non-myasthenic conditions.
  • Contributing factors included atypical clinical presentations, misleading antibody results (low titers, seronegative status), and electrodiagnostic abnormalities.
  • Technical issues and equivocal findings were noted in prior electrodiagnostic studies.

Conclusions:

  • Overdiagnosis of myasthenia gravis is a significant issue, particularly in seronegative patients.
  • Accurate diagnosis necessitates careful consideration of atypical presentations and avoidance of over-reliance on non-specific serological and electrodiagnostic findings.
  • Re-evaluation of suspected MG cases is important to ensure correct diagnosis and management.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.2K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.8K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.0K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.0K
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
605
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
18